The French drug safety agency has approved commercial
sales of a medicine derived from cannabis for the first time in France.
Read: More about dagga (cannabis)
Health Ministry has said in a statement that sales of Sativex,
produced by Britain's GW Pharmaceuticals, will be allowed for the
treatment of muscle spasms associated with multiple sclerosis.
contains marijuana's two best known components – delta 9-THC and
cannabidiol. The company's website says the medicine has already been
launched in 11 countries and approved in more than a dozen others.
number of countries have been easing curbs on the sale of
cannabis-based products for medical use in recent years, and the US
state of Colorado allowed the nation's first legal recreational
marijuana shops to open starting this year.
Cannabis not a cure-all
(AP, January 2014)